PARK2, Recombinant, Human, aa1-465, His-Tag (E3 Ubiquitin-Protein Ligase Parkin, Parkinson Juvenile Disease Protein 2, Parkinson Disease Protein 2)
Catalog No : USB-218423
508.06€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | PARK2, Recombinant, Human, aa1-465, His-Tag (E3 Ubiquitin-Protein Ligase Parkin, Parkinson Juvenile Disease Protein 2, Parkinson Disease Protein 2) | ||
|---|---|---|---|
| Catalog No | USB-218423 | ||
| Supplier’s Catalog No | 218423 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E. coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 53.8 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | ~80% (SDS-PAGE) | ||
| Form | Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 0.4M urea, 10% glycerol. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ~80% (SDS-PAGE) | ||
| Description | The precise function of this gene is unknown; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in this gene are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support. Source: Recombinant corresponding to aa1-465 from human PARK2 protein, fused to His-tag at N-terminus, expressed in E.coli. Molecular Weight: ~53.8kD (485aa) Applications: Suitable for use in SDS-PAGE. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
© 2020 Imugex All Rights Reserved